Fetal growth or gestational age in a woman's pregnancies may modify pregnancy-related breast cancer risk, yet studies of these exposures are few. The authors conducted a population-based case-control study among parous Michigan women aged 50 years using linked Michigan Cancer Registry (1985Registry ( -2004 and Michigan livebirth records . Breast cancer cases (n ¼ 7,591) were matched 1:4 to controls (n ¼ 28,382) on maternal birth year and race. Using conditional logistic regression, the authors examined the associations of gestational age (in weeks) and fetal growth (defined using birth weight percentiles for gestational age) in first and last births with breast cancer risk. Having a small-for-gestational-age or large-for-gestational-age infant at a maternal first or last birth was not associated with breast cancer risk, but having a small-for-gestational-age infant at a last birth at 30 years modestly reduced risk: odds ratio ¼ 0.82 (95% confidence interval: 0.68, 0.98). First delivery at <32 or >41 weeks also modestly reduced risk: odds ratio ¼ 0.80 (95% confidence interval: 0.62, 1.04) or 0.92 (95% confidence interval: 0.85, 0.99), respectively. In the largest case-control study to date, fetal growth was not associated with overall breast cancer risk in women aged 50, and there was some evidence for reduced breast cancer risk for early or late gestational age in first births only. birth weight; breast neoplasms; gestational age; hormones; pregnancy Abbreviations: AGA, appropriate for gestational age; CI, confidence interval; LGA, large for gestational age; LMP, last menstrual period; OR, odds ratio; SEER, Surveillance, Epidemiology, and End Results; SGA, small for gestational age.
The short-and long-term effects of pregnancy on breast cancer risk are well documented (1) (2) (3) . The biologic mechanisms underlying the role of pregnancy in breast cancer etiology, however, are not clear (4, 5) . During pregnancy, several hormonal factors (e.g., estrogens, progesterone, insulin-like growth factor I) are elevated (6) and may influence the development of breast cancer (4, 7) , but it is difficult to directly investigate the associations of pregnancy hormones and later breast cancer risk. Insight into biologic mechanisms may be gained by studying infants' birth characteristics, such as fetal growth or gestational age, which reflect variation in exposure to pregnancy hormones (8, 9) . For example, elevated fetal growth/birth weight may be associated with elevated maternal estrogens and insulin-like growth factor I levels during pregnancy (10) (11) (12) (13) .
Studies of fetal growth and gestational age in a woman's own pregnancies and breast cancer risk are sparse (14) . Five studies have reported results for fetal growth (estimated by using birth weight alone or birth weight adjusted for gestational age as a covariate) and maternal breast cancer risk (8, (15) (16) (17) (18) , with some evidence for an association between high fetal growth and increased breast cancer risk in the 2 largest cohort studies (8, 17) . The few studies of gestational age and breast cancer have reported conflicting results (8, 9, 16, (19) (20) (21) (22) . Two limitations of the current literature include the following: 1) no study has examined fetal growth defined more precisely by birth weight percentiles for gestational age; and 2) although the etiologies of breast cancer histologic subtypes may vary, no study has investigated these associations by histologic subtype.
In light of these limitations and few studies to date, we conducted a large, registry-linked, population-based casecontrol study among parous Michigan women 50 years (predominantly premenopausal) to evaluate the associations of breast cancer with fetal growth and gestational age. We examined exposures in first births, the focus of almost all previous studies (14) , because of the well-established importance of a first full-term pregnancy on both the short-and long-term risk of breast cancer (1) (2) (3) . We examined exposures in the last birth prior to the study reference date, as have 2 previous studies (17, 20) , based on the hypothesis that the hormonal environment during pregnancy may be tumor growth promoting (23, 24) . Age at first and last birth and years since birth are known to modify the influence of pregnancy on subsequent breast risk (1, (25) (26) (27) ; hence, as have others (17, 20, 21) , we examined the potential modifying influence of age at first/last birth and years since first/ last birth on the studied associations.
MATERIALS AND METHODS

Study population
We used the Michigan Birth Registry and the Michigan Cancer Surveillance Program's statewide cancer registry to conduct a statewide, population-based case-control study. Cases had the following eligibility criteria: 1) diagnosed with in situ or invasive first primary breast cancer between 1985 and 2004; 2) aged 20-50 years at diagnosis; 3) having had no previous diagnosis of cancer, except basal or squamous cell carcinoma; 4) being of white or black race according to the Michigan birth file; 5) had their first livebirth in Michigan at age 16 years between 1978 and 2004 before the study reference date (date of diagnosis ¼ study reference date for cases); and 6) resided in Michigan at diagnosis.
Eligible controls, selected from the Michigan Birth Registry, had the same eligibility criteria as cases, except no history of cancer in Michigan between 1985 and 2004 or in the Detroit Surveillance, Epidemiology, and End Results (SEER) Registry for the years 1978-1984 (the area covered by the Detroit SEER Registry accounted for 43.6% of Michigan's population in 1980) (28) . For controls, the study reference date was the individually matched case's diagnosis date. Four controls were randomly selected and individually matched to each case on maternal year of birth and race. The study protocol was approved by the institutional review boards for Michigan State University and the Michigan Department of Community Health.
Study data set creation and record linkage procedures
Cancer to first-birth linkages. By use of the maternal Social Security number, eligible cases (n ¼ 8,413) were identified by linkage of the cancer registry to the birth registry (refer to Web Figure 1 , the first of 2 supplementary figures posted on the Journal's website (http://aje.oupjournals.org) for exclusions made during case selection). To address the concern of false positive linkages of cancer patients to birth files, we randomly selected 591 cases and manually verified their linkages (i.e., hand checked the paper birth certificate for births before 1989 and the computer file for births after 1989 to confirm that the Social Security number, age, first name, and last name in the birth record matched the cancer record); 98% of the linkages were correctly matched. We also identified invalid linkages by comparing the age on the birth record with that on the cancer record. To address the concern of missed linkages (e.g., false negative linkages), for cases with births in 1989 forward (when additional identifiers were available), we compared linkage results using the Social Security number alone with results from a multistage deterministic linkage approach using the Social Security number and 6 additional identifiers (first name, last name, maiden name, infant's last name, alias, date of birth) (29) . Using the multistage linkage approach, we linked 2,444 cases to their first birth as compared with 2,414 linked cases using the Social Security number alone; 1.2% of cases were missed by using Social Security number alone linkage. These results demonstrate that the Social Security number alone is a valid linkage approach. We then excluded the 162 cases identified as having invalid linkages, and the remaining cases (n ¼ 8,251) were matched to 33,004 eligible controls. We also manually verified linkages of birth records for a sample of cases and controls; however, because of the large number of participants, this sample was taken among a subsample of women identified as having potentially invalid linkages based on nonmatching maternal age, birth year, or birth order across births (n ¼ 1,668, 4% of cases and controls). Through manual verification of a sample of birth histories for women, we found nonmatching maternal age to be a good indicator of invalid linkages; hence, we excluded all cases and controls where maternal age did not match across births (about 1% of participants). Among women identified as having possible invalid birth record linkages and whose linkages were manually verified (n ¼ 531), we found 18 women (3.4%) linked to invalid records. After completion of linkage validation work for birth record linkages, 64 cases and 267 controls were excluded (refer to Web Figure 2 for additional details). All the linkage work and linkage validation efforts were performed at the Michigan Department of Community Health to preserve confidentiality of the identifiable data.
Study exposures
Gestational age and birth weight were categorized by using a priori cutpoints (8, 16, 31) (refer to Table 2 for categories). Estimated fetal growth was defined by using published birth weight 1st-99th percentiles for each week of gestation (24-44 weeks) based on US natality data (32) . These birth weight percentiles allow for estimation of fetal growth by a more continuous variable of birth weight for gestational age (32) . We estimated fetal growth using birth weight percentiles by gestational week categorized into 1, 5, and 10 percentile increments and the following categories: small for gestational age (SGA) ¼ birth weights under the 10th percentile by gestational week; appropriate for gestational age (AGA) ¼ birth weights between the 10th and 90th percentiles by gestational week (referent); and large for gestational age (LGA) ¼ birth weights over the 90th percentile by gestational week (33, 34) .
Gestational age based primarily on the date of the last menstrual period (LMP) is prone to misclassification (33, 34) . To address this concern, we first replaced implausible and missing LMP estimates of gestational age (i.e., <20 weeks or >44 weeks) with clinical estimates of gestational age (3,837 births; 4.6%) (32, 34) . Next, we used published cutpoints for gestational weeks 25-35 to identify births with implausibly high birth weights (33) and substituted the clinical estimate of gestational age for the LMP estimate for these births, when available (615 births; 0.7% of births). We also conducted sensitivity analyses using alternative approaches to estimate gestational age and address inaccurate values, described in the Discussion.
All exclusions are detailed in Web Figures 1 and 2. Briefly, we began preliminary analyses with 8,187 cases and 32,725 controls and then excluded 2 controls found to be ineligible, 3 cases and 12 controls missing the study reference month, and 63 cases with breast cancer during pregnancy. For the present analyses, we excluded women who ever had a multiple birth (231 cases (2.8%); 884 controls (2.7%)), as well as women with missing or implausible data on any livebirth record for the following variables: gestational age, birth weight, education, infant's gender, and parity (3.7% of cases and 3.6% of controls excluded). Finally, we excluded 2,270 additional controls matched to excluded cases. The final sample size was 1,491 in situ and 6,100 invasive cases and 28,382 controls.
Statistical analyses
We examined the associations for breast cancer risk (overall and by histologic type) with gestational age and fetal growth in first births for all women and last births for women with 2 livebirths. Odds ratios and 95% confidence intervals were obtained from conditional logistic regression models, conditioned on maternal birth year and race. Potential confounders included age at first and last birth, education at first birth, infant's gender at first and last birth, parity (number of livebirths), and exposures (as appropriate). Although not all potential confounders resulted in a change of 5% for the main effects parameter estimate, we adjusted final models for the same covariate set, as appropriate (Tables 2 and 3 ). On the basis of results from preliminary analyses, gestational age was included as a quadratic term for adjustment purposes.
We evaluated age at first and last birth and years since first and last birth as a priori potential effect modifiers using the conditional likelihood ratio test to compare models with and without interaction terms. Linear trends for a priori categorized exposures were evaluated by using the Wald test, treating the categorical variables as continuous variables. SAS, version 9.2, software (SAS Institute, Inc., Cary, North Carolina) was used for all analyses. All tests were 2 sided, and P < 0.05 indicated statistical significance. Table 1 displays characteristics of study participants by case-control status. By design, cases and controls had similar distributions for age and race. Cases were more likely than controls to have a first live delivery later in the study years; to have greater than a high school education at first birth, 2 livebirths, or 3 livebirths; and to be older at their first birth. About 38% of cases and controls were <40 years of age at the study reference date.
RESULTS
Fetal growth and gestational age at maternal first births
In models conditioned on age and race, mothers of infants with a very low birth weight had reduced breast cancer risk compared with mothers of infants with a birth weight between 2,500 and 3,499 g (<1,500 g: odds ratio (OR) ¼ 0.80, 95% confidence interval (CI): 0.61, 1.05; 1,500-1,999 g: OR ¼ 0.73, 95% CI: 0.56, 0.95), while higher birth weight was not associated with breast cancer (OR ¼ 1.08, 95% CI: 0.89, 1.32) ( Table 2) . Women who delivered at <32 weeks (very preterm delivery), compared with women with a term delivery, had a nonsignificant 20% reduction in breast cancer risk. Women with a postterm delivery (birth at 42 weeks), compared with women with term births, also had a reduced risk of breast cancer (OR ¼ 0.89, 95% CI: 0.83, 0.96). Having an SGA or LGA infant at first birth was not significantly associated with breast cancer risk. In addition, breast cancer risk was not associated with fetal growth, estimated by using birth weight percentiles for gestational age categorized by 5 or 10 percentile increments (data not shown). Adjustment for available potential confounders did not appreciably alter results (Table 3) . LGA, large for gestational age; OR, odds ratio; SGA, small for gestational age.
a Applicable among multiparous women. b Model 1: Odds ratios were derived by conditional logistic regression models with maternal year of birth and maternal race as conditioning variables.
c Model 2: Also adjusted for maternal age at first birth, infant's gender at first birth, parity, gestational age at first birth (only for models where the main effect is birth weight or fetal growth), and fetal growth at first birth (only for models where gestational age is the main effect).
Fetal growth and gestational age at maternal last births
Breast cancer risk was not associated with infants' birth weight or gestational age at a last birth among multiparous women ( Table 3) . Delivery of an SGA infant at a last birth, compared with delivery of an AGA infant, was associated with a nonsignificant reduction in risk of about 9% in the fully adjusted model (OR ¼ 0.91, 95% CI: 0.79, 1.04). Delivery of an LGA infant at a last birth, on the other hand, was not associated with breast cancer risk.
Results by maternal age at index birth
Findings for the associations of breast cancer risk with gestational age and fetal growth at first births were generally similar by maternal age at first birth (<30 years, 30 years) ( Table 4 ). The exception was for women with a postterm first delivery (42 weeks), where the reduction in breast cancer risk was stronger and significant only among women aged 30 years at their first birth (OR ¼ 0.80, 95% CI: 0.68, 0.94; P interaction ¼ 0.36). Results for variation in gestational age at a last birth and breast cancer risk were similar by age at last birth. However, delivery of an SGA infant at a last birth was associated with reduced breast cancer risk among women aged 30 years at last birth (OR ¼ 0.82, 95% CI: 0.68, 0.98) but not among women aged <30 years (OR ¼ 1.01, 95% CI: 0.83, 1.23; P interaction ¼ 0.11). We found limited evidence for modification of the associations for fetal growth and gestational age in first and last births with breast cancer by years since index birth (data not shown).
Results by tumor histologic subtype
We examined associations for gestational age and fetal growth at maternal first and last births with the 2 most common histologic breast tumor subtypes (ductal and lobular) ( Table 5 ). Associations for exposures at first births were similar to results in Table 2 for breast cancer overall. For last birth analyses, although the findings were not significant, d Model 2: Additionally adjusted for maternal age at first birth, age at last birth, infant's gender at last birth, parity, gestational age at last birth (only for models where the main effect is birth weight or fetal growth), and fetal growth at last birth (only for models where gestational age is the main effect).
ductal tumor risk was elevated for women who delivered a preterm infant (<37 weeks) or a postterm infant (42 weeks), lobular tumor risk was reduced for women with preterm or postterm infants, but sample size was limited.
DISCUSSION
In this large, population-based case-control study of parous women aged 50 years, we did not find an association between low or high fetal growth and overall breast cancer risk. We found some evidence that mothers who had an early (<32 weeks) or late (42 weeks) first delivery had reduced risk of breast cancer compared with mothers of term infants. Results were generally not modified by age at birth or years since birth. In this first investigation of gestational age and fetal growth by histologic subtypes of breast cancer, no major differences were found when associations were examined separately for ductal and lobular breast tumors.
An association between elevated fetal growth and increased breast cancer risk is biologically plausible, given that elevated fetal growth or birth weight has been associated with elevated maternal estrogens and insulin-like growth factor I levels during pregnancy (10, 11, 35, 36) . Few studies, however, have examined estimated fetal growth and breast cancer. Three studies have reported null findings (15, 16, 18) , and 2 found a small (about 10%) increased risk of breast cancer associated with higher fetal growth at a first (8) and most recent (17) birth. Birth weight, a cross-sectional measure, is influenced by duration of gestation and the rate of fetal growth (37) . To estimate fetal growth by using birth weight, the influence of gestational age must be removed. Adjustment for gestational age as a covariate in a multivariable model containing birth weight is one approach to remove the influence of gestational age, which has been used by all previous studies of fetal growth and breast cancer. Another approach is to use reference birth weight percentiles at each gestational age, which may allow for more complete adjustment for gestational age and does not assume a potentially inappropriate relation between gestational age and fetal growth, as do other approaches (e.g., linear) (32). In our study, however, we found little evidence for an overall association between fetal growth estimated via birth weight with gestational age as a covariate in the same multivariable model and birth weight percentiles for gestational age (using various cutpoints (5, 10 percentile increments) or the categories SGA, AGA, LGA). The exception was for women with a last birth at age 30 years. Among this subgroup, delivery of an SGA infant at a last birth was associated with reduced breast cancer risk. However, in this same subgroup, delivery of an LGA infant was not associated with breast cancer risk.
In our study, women with an early first delivery (<32 weeks vs. term) had a nonsignificant 20% reduction in risk, while gestational age at last births was unrelated to breast cancer. In contrast, 3 registry-based cohort studies and 1 large registry-based case-control study have reported some Abbreviations: AGA, appropriate for gestational age; CI, confidence interval;
LGA, large for gestational age; OR, odds ratio; SGA, small for gestational age.
a Applicable among multiparous women. b Includes 7,591 cases and 28,382 controls. Odds ratios derived by conditional logistic regression models with maternal year of birth and maternal race as conditioning variables and adjusted for parity, years since first birth, infant's gender at first birth, gestational age at first birth (only for models where the main effect is birth weight or fetal growth), and fetal growth at first birth (only for models where gestational age is the main effect).
c Among women with 2 livebirths (5,181 cases; 18,032 controls). Odds ratios were derived by conditional logistic regression models with maternal year of birth and maternal race as conditioning variables and adjusted for parity, age at first birth, years since last birth, infant's gender at last birth, gestational age at last birth (only for models where the main effect is birth weight or fetal growth), and fetal growth at last birth (only for models where gestational age is the main effect).
evidence for increased risk of breast cancer among women with shorter gestations, although not all studies reported statistically significant findings (16, (20) (21) (22) . Similar to our findings, an earlier small US registry-based study reported a nonsignificant reduction in breast cancer risk among women who had a preterm first birth (19) . In addition to shorter gestation, we also found that women with a postterm first delivery had reduced breast cancer risk. Only 1 previous study examined longer gestation (>40 weeks) and breast cancer (20) and reported no association.
The reasons for discrepancies across studies of gestational age and breast cancer risk are unclear. Our findings could be limited by unmeasured potential confounders, such as maternal prepregnancy body mass index and pregnancy complications. Both low and high body mass indexes are associated with increased risk of preterm delivery (38, 39) . Obesity is a risk factor for pregnancy conditions (preeclampsia, gestational diabetes) and congenital abnormalities that, in addition to influencing fetal growth, may also result in a medically indicated preterm delivery (39) (40) (41) . Because high body mass index is associated with reduced premenopausal breast cancer risk (42) , maternal body mass index may be a potential confounder of our findings for women with preterm first births. Future studies of infants' birth characteristics and breast cancer should examine the role of maternal body mass index and pregnancy complications.
Several additional limitations must be considered. First, although most data items, including demographics, parity, and birth weight, have been shown to be accurately reported on the birth certificate (43) (44) (45) (46) (47) , accuracy of gestational age is a concern (48). However, we used published approaches (33, 34) to reduce misclassification of gestational age (refer to Materials and Methods). We also conducted 2 sensitivity analyses that involved reanalyzing associations for first births, including 1) using clinical estimates of gestational age instead of LMP estimates and 2) using LMP estimates but excluding only births with missing or implausible gestational ages. The results were similar to those presented. Another limitation was that our study was not adequately powered to examine findings for in situ and invasive cancers separately. However, in sensitivity analyses excluding in situ cases, the results were similar to those presented.
Controls may have been diagnosed with breast cancer in a different state or during 1978-1984, before the Michigan statewide cancer registry began. However, we linked controls to the Detroit SEER Registry (about 60% of the sample) and found only 8 controls diagnosed with breast cancer before the age of 51 years during 1978-1984. Extension of this estimate to the entire state indicated that 0.05% of controls may have been misclassified. Another limitation is the potential for missing exposure or inaccurate parity data if women moved out of Michigan and had additional LGA, large for gestational age; OR, odds ratio; SGA, small for gestational age.
a Applicable among multiparous women. b Odds ratios were estimated separately for ductal versus control and lobular versus control derived by conditional logistic regression models with maternal year of birth and race as conditioning variables and adjusted for parity, age at first birth, infant's gender at first birth, gestational age at first birth (only for models where the main effect is birth weight or fetal growth), and fetal growth at first birth (only for models where gestational age is the main effect). Ductal tumors were classified by using ICD-O-3 code 8500, and lobular tumors were classified by using ICD-O-3 code 8520.
c Odds ratios were estimated separately for ductal versus control and lobular versus control, derived by conditional logistic regression models with maternal year of birth and race as conditioning variables and adjusted for age at first birth, age at last birth, infant's gender at last birth, parity, gestational age at last birth (only for models where the main effect is birth weight or fetal growth), and fetal growth at last birth (only for models where gestational age is the main effect), and are among women with 2 livebirths (n ¼ 23,204). nonresident births. Most likely this would have resulted in nondifferential misclassification, which may have attenuated the associations for last birth analyses.
Another concern is the potential bias due to requiring study participants to have had their births as Michigan residents and for cases to be diagnosed in Michigan. Women who do not move out of Michigan may have different characteristics compared with women who permanently move out of state, which could be related to exposures of interest. On the basis of a US Census report of persons who moved out of state during 1990-1995, those who moved had a higher education and income and were more likely to be non-Hispanic white (49) . Thus, our results are not applicable to US women of all race/ethnicities and socioeconomic groups. However, we did find that the prevalences in controls for birth weight categories and preterm/very preterm first births in our study were very similar to those in a population-based case-control study using New York birth certificates for first births during 1978-1994 (16) . As have previous studies (14) , our study did not have information on other well-studied breast cancer risk factors, such as breastfeeding. Finally, we also lacked information on fetal deaths; Michigan did not collect identifiers for fetal death reports during most of the study period.
In conclusion, in the largest population-based case-control study conducted to date, women with a very preterm or posterm delivery at their first birth tended to have reduced risk of breast cancer compared with mothers of term infants. We found limited evidence for an overall association between fetal growth and maternal breast cancer risk. We also found few differences in associations for gestational age and fetal growth with breast cancer by histologic subtype. Future studies of these associations, in particular with information on pre-and postpregnancy body size, pregnancy complications, and other tumor characteristics such as hormone-receptor status, may provide further insight into the biologic mechanisms underlying the role of pregnancy in breast cancer etiology.
